期刊文献+

西拉普利和缬沙坦与心房颤动犬心房肌钙激活蛋白酶表达及心房结构重构关系的实验研究 被引量:1

An experimental study of the effects of cilazapril and valsartan on the expression of atrial calpains and atrial structural remodeling in dogs with atrial fibrillation
原文传递
导出
摘要 目的观察西拉普利和缬沙坦对心房颤动(房颤)犬心房肌钙激活蛋白酶(calpains)mR-NA和蛋白表达及心房结构重构的影响。方法27只犬随机分为假手术组、对照组、西拉普利组和缬沙坦组。对照组、西拉普利组和缬沙坦组犬以400次/min心房快速起搏6周,建立房颤犬模型。假手术组犬埋植起搏器后不起搏。测量左心房容积及收缩功能变化,记录房颤诱发及维持情况,检测心房肌calpains mRNA和蛋白表达,观察心房肌病理组织学和超微结构改变。结果西拉普利组和缬沙坦组犬心房肌calpain I mRNA和蛋白表达较假手术组增多(P〈0.05),但较对照组显著减少(P〈0.01)。各组犬心房肌calpain I蛋白表达与肌溶解高度相关(r=0.89,P〈0.01)。各组犬心房肌calpain Ⅱ mRNA和蛋白表达差异无统计学意义。与对照组相比,西拉普利组和缬沙坦组犬心房肌病理组织学和超微结构改变显著减轻,左心房及左心耳容积明显减小,左心房收缩功能显著增强,房颤诱发率和持续时间明显降低。结论房颤犬心房肌calpain I mRNA和蛋白表达显著上调。西拉普利和缬沙坦能明显抑制房颤犬心房肌calpain I表达,防治心房结构重构,减少房颤发生。 Objective The present study was designed to evaluate the effects of cilazapril and valsar-tan on the mRNA and protein expressions of atrial calpain Ⅰ and calpain Ⅱ , and atrial structural remodeling in dogs with atrial fibrillation (AF) induced by chronic, rapid atrial pacing. Methods Twenty-seven dogs were randomly divided into the sham-operated group ( n = 6 ), control group ( n = 7 ), cilazapril group ( n = 7 ) and val- sartan group( n = 7 ). The dogs in the control group, cilazapril group and valsartan group were subjected to rapid atrial pacing at 400 bpm for 6 weeks, whereas the pacemakers in the sham-operated group were not operational. The dogs in the cilazapril and valsartan groups were given cilazapril( 1 mg·kg^-1·d^-1 ) or valsartan(30 mg·kg^-1·d^-1) respectively from 1 week before pacing until pacing was stopped. Transthoracic and transoesopha-geal echocardiographic examinations were performed to detect the changes in left atrium volume and contractile function. The inducibility and dtiration of AF were measured in all groups. The mRNA expressions of atrial calpain Ⅰ and calpain Ⅱ were semi-quantified by reverse transcription polymerase chain reaction. The protein levels of calpain Ⅰ and calpain Ⅱ in atrial myocardium were measured by Western-blot method. Patho- histological and ultrastructural changes in atrial tissue were assessed by light and electron microscopy. Results After 6-week pacing, the mRNA and protein expressions of calpain I were up-regulated dramatically in the control group compared to those in the sham-operated group, and the protein expressions of calpain I in all groups correlated closely with the myalysis (r = 0. 89 ,P 〈 0.01 ). Cilazapril and valsartan could significantly inhibit the mRNA and protein expressions of calpain I. No differences were found in the mRNA and protein expressions of calpain Ⅱ among the groups. Compared with the control group, dramatically smaller left atrium and left atrial appendage volumes and markedly improved atrial contractile function were observed in the cilazapril and valsartan groups. Compared with atrial myocytes obtained from the sham-operated group dogs, atrial myo- cytes from the control group dogs showed a reduced number of sarcomeres, a significantly higher myolytic area of atria (24. 3% vs. 3.1% , P 〈 0. 01 ), increased vacuolization and dissolution. Cilazapril and valsartan could effectively prevent the pathohistological and uhrastructural changes induced by chronic rapid atrial pacing, dra- matically decreased the area of myolysis ( P 〈 0. 05 ) and significantly reduced the inducibility and duration of AF. Conclusions Cilazapril and valsartan could inhibit calpain I up-regulation, suppress atrial structural re-modeling, and orevent the induction and maintenance of AF in chronic, raoid atrial pacing dogs.
出处 《中华心律失常学杂志》 2008年第4期292-297,共6页 Chinese Journal of Cardiac Arrhythmias
基金 中国博士后基金(2005038210),黑龙江省教育厅新世纪创新人才基金(1152-NCET-011),黑龙江省科技攻关项目(GB07C32401),哈尔滨市科技攻关项目(2004AA9CS196-8),黑龙江省博士后基金(LRB04-269)
关键词 心房颤动 钙激活蛋白酶 血管紧张素 结构重构 Atrial fibrillation Calpains Angiotensin Structural remodeling Dog
  • 相关文献

参考文献3

二级参考文献37

  • 1裴德安,李莉,徐志云,邹良健,张宝仁,黄盛东,郝家骅,王志农,陆方林.心房颤动患者心房肌组织醛固酮水平和CYP11B2基因与心房结构重构研究[J].中华心律失常学杂志,2006,10(5):349-354. 被引量:11
  • 2Cha TJ, Ehrlich JR, Zhang L, et al. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation, 2004,109: 412-418.
  • 3Brundel BJ, Kampinga HH, Henning RH. Calpain inhibition prevents pacing induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc Res, 2004, 62: 521-528.
  • 4Xu J, Cui G, Esmailian F, et al. Atrial extra cellular matrix remodeling and the maintenance of atrial fibrillation. Circulation, 2004, 109:363-368.
  • 5Ausma J, van-der Velden HM, Lenders MH, et al. Reverse structural and gap-junctional remodeling after prolonged strial fibrillation in the goat. Circulation, 2003, 107:2051-2558.
  • 6Manios EG, Kanoupakis EM, Chlouverakis GI, et al. Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence. Cardiovasc Res, 2000, 47: 244- 253.
  • 7Ausma J, Coumans WA, Duimel H, et al. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res, 2000, 47:788-796.
  • 8Klein G, Schroder F, Vogler D, et al. Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation. Role of phosphatase 2A. Cardiovasc Res, 2003, 59:37-45.
  • 9Matsumura Y, Kusuoka H, Inoue M, et al. Protective effect of the protease inhibitor leupeptin against myocardial stunning. J Cardiovasc Pharmacol, 1993, 22 : 135-142.
  • 10Urthaler F, Wolkowicz PE, Dignerness SB, et al. MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKC epsilon proteolysis in reperfused ferret hearts. Cardiovasc Res, 1997, 35:60-67.

共引文献4

同被引文献9

  • 1李为民,李悦,薛竟宜,孔一慧,潘尚哈,徐岩松,韩薇,杨树森.心房颤动犬心房肌肾素-血管紧张素系统改变[J].中华心律失常学杂志,2005,9(2):123-127. 被引量:15
  • 2史爱武,孔祥清,王晓伟,吴延虎,周肖英,盛燕辉,杨荣,周蕾,许迪,曹克将,陆凤翔.应用经胸超声心动图评估快速左心耳起搏心房颤动模型心脏结构及功能的变化[J].中国组织工程研究与临床康复,2007,11(9):1628-1631. 被引量:5
  • 3Healey JS,Morillo CA,Connolly SJ.Role of the renninangiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.Curr Opin Cardiol,2005,20:31-37.
  • 4Bourassa MG.Angintensin Ⅱ inhibition and prevention of atrial fibrillation and stroke.J Am Coll Cardiol,2005,45:720-721.
  • 5Okazaki H,Minamino T,Tsukamoto O,et al.Angiotansin Ⅱ type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.Hypertens Res,2006,29:277-284.
  • 6The SOLVD Investigators.Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.N Engl J Med,1991,325:293-302.
  • 7Li D,Shinagawa K,Pang L,et al.Effects of angiotensin converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.Circulation,2001,104:2608-2614.
  • 8Milliez P,Girerd X,Plouin PF,et al.Evidence for an increase rate of cardiovascular events in patients with primary aldosteronsim.J Am Coll Cardiol,2005,45:1243-1248.
  • 9赵晖,于建华.氯沙坦对阵发性心房颤动患者血清脑钠素及血管紧张素Ⅱ水平的干预作用[J].临床心血管病杂志,2008,24(8):627-628. 被引量:7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部